Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironment

• Published in: Translational oncology Vol. 35; p. 101733
• Main Authors: Li, Lin, Liu, Jianyu, Wang, Wenzheng, Fu, Yingqiang, Deng, Yuhan, Li, Xin, Liu, Zhuolin, Pang, Yuheng, Xu, Yangyang, Yan, Meisi, Li, Zhigao
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2023; Neoplasia Press; Elsevier
• Subjects: Breast cancer 1; Cancer stem cells (CSCs) 2; Lymph node metastasis 5; Single-cell RNA sequencing (scRNA-seq) 4; Tumor immune microenvironment (TIME) 3; Tumor immune microenvironment (TIME) 3; Lymph node metastasis 5; Single-cell RNA sequencing (scRNA-seq) 4; Cancer stem cells (CSCs) 2; Breast cancer 1
• ISSN: 1936-5233; 1936-5233
• DOI: 10.1016/j.tranon.2023.101733

•Breast cancer stem cells (CSCs) alter tumor immune microenvironment to promote lymph node metastasis.•RAC2 and PTTG1 double-positive CSCs exhibit stem-like features and are enriched in metastatic lymph nodes.•CSCs impact the evolution of adaptive and innate immune cells, contributing to metastasis progression.•Findings provide insights for targeting therapy against highly stem-like CSCs in metastatic lymph nodes.•Identification of RAC2 and PTTG1 double-positive CSCs provides new insights for developing targeted therapies. Breast cancer progression and metastasis are governed by a complex interplay within the tumor immune microenvironment (TIME), involving numerous cell types. Lymph node metastasis (LNM) is a key prognostic marker associated with distant organ metastasis and reduced patient survival, but the mechanisms underlying its promotion by breast cancer stem cells (CSCs) remain unclear. Our study sought to unravel how CSCs reprogram TIME to facilitate LNM. Utilizing single-cell RNA sequencing, we profiled TIME in primary cancer and corresponding metastatic lymph node samples from patients at our institution. To verify the derived data, we cultured CSCs and performed validation assays employing flow cytometry and CyTOF. Our analysis revealed distinct differences in cellular infiltration patterns between tumor and LNM samples. Importantly, RAC2 and PTTG1 double-positive CSCs, which exhibit the highest stem-like attributes, were markedly enriched in metastatic lymph nodes. These CSCs are hypothesized to foster metastasis via activation of specific metastasis-related transcription factors and signaling pathways. Additionally, our data suggest that CSCs might modulate adaptive and innate immune cell evolution, thereby further contributing to metastasis. In summary, this study illuminates a critical role of CSCs in modifying TIME to facilitate LNM. The enrichment of highly stem-like CSCs in metastatic lymph nodes offers novel therapeutic targeting opportunities and deepens our understanding of breast cancer metastasis. [Display omitted]